Hematology, Transfusion and Cell Therapy (Apr 2023)
Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis
Abstract
No abstracts available.
